PLAUR and neoplasm: While novel uPAR-targeted OVs continue to be developed [264], open questions for future research remain, such as the OVs’ exact mechanism of action or effects on other relevant pro-cancer uPAR-positive stromal cells such as TAMs, one of the prominent tumor-promoting stromal cells.